STAT
MAY 8, 2024
Since March, when the first reported cases of H5N1 bird flu began showing up in dairy cattle in Texas, the Food and Drug Administration has been asking farmers to discard any milk from infected animals. Initially, spotting tainted milk was believed to be fairly easy because cows that get sick with H5N1 begin producing milk that is thick and yellowish.
PharmaVoice
MAY 8, 2024
Partnerships have been key to building the company’s AI capabilities and patient-focused R&D, said AstraZeneca’s head of U.S. oncology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 8, 2024
Yes, it’s possible to have a worm living in your brain — in fact, it’s far more common than you might think, said Dr. David Hamer, a professor of global health and medicine at the Boston University School of Public Health, who also directs a travel clinic at Boston Medical Center. Brain worms became a topic of public fascination Wednesday after the The New York Times reported that presidential candidate Robert F.
BioPharma Dive
MAY 8, 2024
Intellectual property is the foundation of the drug industry’s business model. This database will track key patent expiry dates for 30 top-selling medicines.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 8, 2024
Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday. The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.
PharmaTech
MAY 8, 2024
The company is presenting preclinical data at the American Society of Gene & Cell Therapy annual meeting that supports the potential of the company’s CAP-002 gene therapy for correcting neurological phenotypes associated with genetic epilepsy due to syntaxin-binding protein 1 (STXBP1) mutations.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
MAY 8, 2024
The move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but struggled to sell it amid competition and the emergence of rare but serious side effects.
STAT
MAY 8, 2024
In the latest bid to widen access to medicines, a nonprofit is sending technology and materials for making expensive CAR-T cell therapies to the Brazilian government and an Indian manufacturer that will, in turn, look to provide the treatments available at a fraction of current prices in the U.S. The deals will initially involve manufacturing cell therapies for combating lymphoma and leukemia, which carry price tags in the hundreds of thousands of dollars in wealthy nations.
European Pharmaceutical Review
MAY 8, 2024
New data from a Phase IIa trial in moderate-to-severe atopic dermatitis has demonstrated that a novel monoclonal antibody (mAb) could facilitate dosing every 12 weeks for induction therapy. This is due to a 31-day half-life at anticipated therapeutic dose levels, Inmagene Biopharmaceuticals confirmed. Humanised anti-OX40 IgG1 mAb IMG-007 works via a silenced antibody -dependent cellular cytotoxicity (ADCC) function, Inmagene explained.
STAT
MAY 8, 2024
At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced in a recall notice on Wednesday. The product is made by Tandem Diabetes Care, which sells touchscreen insulin pumps and an accompanying app to help dose the medicine. Around 300,000 people use the technology.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
MAY 8, 2024
The first commercial sales of Spectral AI's DeepView wound imaging system for burns are due to start in the UK, its first market, later this year
STAT
MAY 8, 2024
The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure. Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program.
pharmaphorum
MAY 8, 2024
Regeneron’s gene therapy for otoferlin-related hearing loss restored hearing to normal levels in one profoundly deaf child within just 24 weeks
STAT
MAY 8, 2024
Tolerance is the holy grail in calming autoimmune disease, a truce in the immune system’s faulty battle against the body’s own fabric. In type 1 diabetes, immune fighters attack beta cells in the pancreas that produce insulin, the hormone that controls glucose levels in the blood. Scientists have tried to enlist defenders in the form of regulatory T-cells, or Tregs, extra white blood cells whose job is to tamp down the misguided immune response.
pharmaphorum
MAY 8, 2024
Get to know Ariel Buda-Levin from the IPG Health Network better with these 12 insightful questions. Learn more about her background, expertise, and experiences.
STAT
MAY 8, 2024
Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction of a vast universe of biomolecules, a fundamental advance that may help scientists unravel poorly-understood aspects of biology and disease. The new AI, dubbed AlphaFold 3, improves upon earlier versions of the model by predicting not just the structure of proteins, but all the molecules that interact with them in cells, including RNA, DNA, ions, and other small molecules.
Express Pharma
MAY 8, 2024
The US Food and Drug Administration (FDA) will convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) on Monday, June 10, 2024, to discuss donanemab, which Eli Lilly and Company (NYSE: LLY) has submitted for the treatment of early symptomatic Alzheimer’s disease. The open public hearing portion of the meeting will be conducted virtually.
STAT
MAY 8, 2024
As the U.S. grapples with the lasting effects of the Covid-19 pandemic, it is important to highlight the ongoing challenges faced by the 7 million immunocompromised Americans. For them, the battle against Covid-19 is far from over. Often overlooked or sidelined by newsmakers and policymakers, these individuals continue to confront a heightened risk of severe illness or death due to their compromised immune systems, while society largely adjusts to life with the virus.
Express Pharma
MAY 8, 2024
In April 2024, the healthcare industry reported 96 deals worth $13.4 billion, compared to the last 12-month (April 2023 to March 2024) average of 94 deals worth $20 billion. Vertex Pharmaceuticals Inc, a biotechnology company, to acquire Alpine Immune Sciences Inc, a clinical stage biotechnology company, for a consideration of approximately $4.9 billion in cash; Ono Pharmaceutical, an immuno-oncology company to acquire Deciphera Pharmaceuticals Inc, a biopharmaceutical company focused on disco
STAT
MAY 8, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today we ponder, how much will the advisory committee meeting for Lilly’s donanemab matter? Send me your thoughts, and as always, any ideas or tips: elaine.chen@statnews.com.
pharmaphorum
MAY 8, 2024
Selective serotonin reuptake inhibitors (SSRIs) are the first-line drug therapy of choice for most people suffering from depression but often fail to work effectively. Now, a study suggests simple blood test could help predict those who will benefit.
STAT
MAY 8, 2024
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this far, because it is an accomplishment, after all. The next step, of course, is to somehow forge ahead. And why not? Just consider the alternatives. On that optimistic note, please join us for a needed cup or three of stimulation. Our choice today is salted caramel, which reminds us of the breezy Jersey shore.
Express Pharma
MAY 8, 2024
Merak Ventures, a sector-agnostic early-stage, B2B venture capital (VC) firm, has announced a new investment in Atomgrid, an R&D-first platform for contract development, manufacturing, and sourcing of Specialty Chemicals. According to the company’s statement, Merak Ventures led the INR 10 Cr seed round, in which other venture firms including Dexter Ventures, Upsparks, Point One Capital and the founders of UniCards (Nitin Gupta and Prateek Jindal) also participated.
STAT
MAY 8, 2024
In 2020, James Sulzer’s personal and professional lives suddenly intersected after his then 4-year-old daughter sustained a devastating injury. As a researcher and associate professor in physical medicine and rehabilitation at Case Western Reserve University, Sulzer has spent his life tinkering with tools that help patients with neurological conditions.
Pharma Times
MAY 8, 2024
Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications
pharmaphorum
MAY 8, 2024
As pharma R&D jobs face deep cuts, workers struggle with an uncertain future. Can the industry recover or will more jobs disappear?
Pharmacy Joe
MAY 8, 2024
In this episode, I’ll discuss what blood gas parameters can make you suspect methemoglobinemia. Episode 920: What blood gas parameters indicate possible methemoglobinemia? Subscribe on iTunes , Android , or Stitcher Methemoglobin is formed when the ferrous irons of heme are oxidized to the ferric state. The ferric hemes of methemoglobin are unable to bind oxygen, therefore, causing a functional anemia.
pharmaphorum
MAY 8, 2024
Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.
Express Pharma
MAY 8, 2024
MetP Pharma AG, leveraging the proprietary nose-to-brain drug delivery technology BrainDos in internal and external product development and manufacturing programs, recently announced its preclinical research results. According to the company’s statement, the results support the further development of semaglutide in an oleogel formulation using the BrainDos drug delivery technology.
pharmaphorum
MAY 8, 2024
FDA advisors will meet on 10th June to discuss Eli Lilly's Alzheimer's candidate donanemab, shortly after casting an eye over Lykos' MDMA-based psychedelic for PTSD.
Pharmaceutical Technology
MAY 8, 2024
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, citing a surplus of updated vaccines.
Express Pharma
MAY 8, 2024
According to the statement released by GlobalData, 2023 marked a significant upsurge in FDA approvals, particularly for groundbreaking treatments such as cell and gene therapies. This surge highlights not just advancements in medical technology but also provides substantial opportunities for manufacturers specialising in these cutting-edge therapies.
The Pharmacist
MAY 8, 2024
The government has pledged to support pharmacist prescribers with tools to reduce unnecessary antimicrobial prescriptions as part of its five-year plan to tackle antimicrobial resistance (AMR). Such tools could make use of digital technologies including artificial intelligence (AI), but this would depend on ‘fully integrated digital systems’ with the right data governance permissions, the government said. […] The post AMR support tools 'critically important' for pharmacist prescr
Pharmaceutical Technology
MAY 8, 2024
Coinfections can complicate disease management and hence continued surveillance and targeted intervention strategies are needed.
The Pharmacist
MAY 8, 2024
Community pharmacies who are not able to provide trainee pharmacists with a designated prescribing practitioner (DPP) for the foundation year 2025/2026 should withdraw their application to provide a placement, the National Pharmacy Association (NPA) has warned. NHS England has previously encouraged members to express an interest in providing a placement 'even if they did not […] The post Pharmacies told to withdraw training placements lacking a DPP appeared first on The Pharmacist.
Expert insights. Personalized for you.
363 
Let's personalize your content